Overview

Ranolazine and Microvascular Angina by PET in the Emergency Department

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the effectiveness of Ranolazine for the treatment chest pain from disease of small vessels of the heart also known as 'microvascular angina'.
Phase:
Phase 4
Details
Lead Sponsor:
Yale University
Collaborator:
Gilead Sciences
Treatments:
Ranolazine